Research shows how the toxin of Sicarius levii damages cell membranes, helps explain cases of necrosis, and can guide new ways to treat recluse spider bites.
A significant scientific discovery revealed how the venom of a Chilean spider can attack human cells with high precision. The analyzed toxin belongs to Sicarius levii, a six-eyed sand spider found in Chile and a relative of the violin spider.
According to recently published research led by Alexandra Sundman, the venom contains an enzyme capable of binding to the cell surface and quickly initiating damage. This mechanism helps explain why some recluse spider bites can cause necrosis, severe skin wounds, and complications in red blood cells and kidneys.
Toxin structure reveals direct attack on cells
The discovery resulted from a study conducted by researchers who have been investigating venoms for over two decades, in collaboration with scientist Greta Binford. As the work describes, the toxin acts as an enzyme, that is, a protein capable of accelerating chemical reactions.
-
Xiaomi innovates once again and introduces a giant 620-liter refrigerator, silent compressor, 99.99% antibacterial technology, integrated Wi-Fi, 18 internal compartments, and a surprising price equivalent to R$ 1,840 in China.
-
Europe discovers “urban mine” with lithium hidden in electronics, used batteries, and old turbines, and could recover more than 55,000 tons per year by 2050.
-
Project created by a UFS student defeats European competitors in an engineering award held in Paris and highlights the advancement of Brazilian science with an innovative solution, developed in a public academic environment and recognized by international experts in the technological field.
-
Scientists drill 8,000 feet of ice in Antarctica and race against time before the hole freezes over again to bury the world’s deepest seismometers and turn the South Pole into a giant ear for earthquakes across the entire planet.
The enzyme attaches to the cell membrane and glides over the surface like a “lawnmower.” It then cuts parts of the molecules present in this layer and alters their structure. According to an observation made by Dan Lajoie, a former lab student, the toxin transforms these molecules into unusual ring shapes.
This process weakens the cells and can lead the immune system to attack them. As a result, widespread tissue death occurs, a phenomenon known as necrosis.
Venom affects humans and insects in different ways
Researchers still do not know why these toxins cause necrosis in humans. At the same time, in insects, they seem to primarily affect nerve cells, precisely the structures linked to the spiders’ hunting behavior.
Both effects are likely related to damaged or reorganized cell membranes. For this reason, the study draws attention by showing how the venom acts even before causing visible symptoms.
X-rays show how the enzyme is activated
To better understand the mechanism, the team crystallized the Chilean spider toxin and used X-rays during its binding to target molecules. The analysis showed the molecules positioned in the enzyme’s “mouth,” at the exact point where the cut occurs.
The comparison between the bound and unbound toxin revealed important changes in the protein structure. Thus, scientists observed that the enzyme seems to be activated as soon as it encounters the cell surface. This detail is essential to understand how the venom initiates damage in the organism.
Recluse spiders live in dark and protected places
Recluse spiders usually occupy dark, covered, and low-traffic environments. They can appear in wood piles, closets, and pillowcases, which increases the risk of accidental contact with people.
These spiders are not aggressive and usually bite only when they feel threatened. The most common symptom is a severe skin wound, which in some situations may require grafts.
The toxin can also damage red blood cells and cause life-threatening kidney failure. This scenario makes correct diagnosis even more important.
Difficult diagnosis increases medical challenge

Lesions caused by recluse spiders can be mistaken for wounds caused by bacteria. Among them is methicillin-resistant Staphylococcus, mentioned in the base text as an example of clinical similarity.
Currently, there are no approved treatments in the United States for this type of bite. However, antivenoms are available in South America, a region where related species are also found.
This difference reinforces the importance of better understanding the action of toxins and their effects on human cells.
Research may guide new treatments
The main expectation of scientists is to use this knowledge to develop new forms of treatment. One possibility would be to prevent the toxin from binding to the cell surface.
Another strategy would be to chemically modify the enzyme’s action, blocking its destructive effect. Thus, research on the Sicarius levii may help reduce the damage caused by recluse spider bites.
What do you think should be a priority for science: creating new treatments for severe bites or expanding knowledge on how venoms act on human cells?

Be the first to react!